Psomagen
Private Company
Total funding raised: $17M
Overview
Psomagen is a well-established, US-based contract laboratory service provider specializing in multiomics technologies and data analysis. It differentiates itself through its dual CLIA/CAP accreditation, status as a certified service provider for leading technology platforms like 10x Genomics and Olink, and a collaborative, client-focused approach. The company serves a broad market from academic and biopharma research to clinical diagnostics, leveraging a wide portfolio of sequencing and analytical technologies to make cutting-edge omics accessible and affordable.
Technology Platform
Integrated ecosystem of third-party multiomics platforms (Illumina, PacBio, Oxford Nanopore, 10x Genomics, Olink, Bruker) with CLIA/CAP-accredited laboratory workflows and bioinformatics analysis services.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Psomagen competes in a fragmented but competitive market. Key competitors include large global CROs (e.g., Labcorp, Eurofins), specialized genomics service providers (e.g., Azenta, GENEWIZ), and university core facilities. Its differentiation lies in its broad multiomics portfolio, certified partner status with leading platforms, and dual CLIA/CAP accreditation for research-to-clinical support.